Potent Modification of Low Density Lipoprotein by Group X Secretory Phospholipase A2 Is Linked to Macrophage Foam Cell Formation

Kohji Hanasaki, Katsutoshi Yamada, Shigenori Yamamoto, Yoshikazu Ishimoto, Akihiko Saiga, Takashi Ono, Minoru Ikeda, Mitsuru Notoya, Shigeki Kamitani, Hitoshi Arita

Journal of Biological Chemistry · 2002 · 160 citations · 67 references

DOIFull text

Open access

Concepts

Abstract

The deposition of cholesterol ester within foam cells of the artery wall is fundamental to the pathogenesis of atherosclerosis. Modifications of low density lipoprotein (LDL), such as oxidation, are prerequisite events for the formation of foam cells. We demonstrate here that group X secretory phospholipase A2 (sPLA2-X) may be involved in this process. sPLA2-X was found to induce potent hydrolysis of phosphatidylcholine in LDL leading to the production of large amounts of unsaturated fatty acids and lysophosphatidylcholine (lyso-PC), which contrasted with little, if any, lipolytic modification of LDL by the classic types of group IB and IIA secretory PLA2s. Treatment with sPLA2-X caused an increase in the negative charge of LDL with little modification of apolipoprotein B (apoB) in contrast to the excessive aggregation and fragmentation of apoB in oxidized LDL. The sPLA2-X-modified LDL was efficiently incorporated into macrophages to induce the accumulation of cellular cholesterol ester and the formation of non-membrane-bound lipid droplets in the cytoplasm, whereas the extensive accumulation of multilayered structures was found in the cytoplasm in oxidized LDL-treated macrophages. Immunohistochemical analysis revealed marked expression of sPLA2-X in foam cell lesions in the arterial intima of high fat-fed apolipoprotein E-deficient mice. These findings suggest that modification of LDL by sPLA2-X in the arterial vessels is one of the mechanisms responsible for the generation of atherogenic lipoprotein particles as well as the production of various lipid mediators, including unsaturated fatty acids and lyso-PC. The deposition of cholesterol ester within foam cells of the artery wall is fundamental to the pathogenesis of atherosclerosis. Modifications of low density lipoprotein (LDL), such as oxidation, are prerequisite events for the formation of foam cells. We demonstrate here that group X secretory phospholipase A2 (sPLA2-X) may be involved in this process. sPLA2-X was found to induce potent hydrolysis of phosphatidylcholine in LDL leading to the production of large amounts of unsaturated fatty acids and lysophosphatidylcholine (lyso-PC), which contrasted with little, if any, lipolytic modification of LDL by the classic types of group IB and IIA secretory PLA2s. Treatment with sPLA2-X caused an increase in the negative charge of LDL with little modification of apolipoprotein B (apoB) in contrast to the excessive aggregation and fragmentation of apoB in oxidized LDL. The sPLA2-X-modified LDL was efficiently incorporated into macrophages to induce the accumulation of cellular cholesterol ester and the formation of non-membrane-bound lipid droplets in the cytoplasm, whereas the extensive accumulation of multilayered structures was found in the cytoplasm in oxidized LDL-treated macrophages. Immunohistochemical analysis revealed marked expression of sPLA2-X in foam cell lesions in the arterial intima of high fat-fed apolipoprotein E-deficient mice. These findings suggest that modification of LDL by sPLA2-X in the arterial vessels is one of the mechanisms responsible for the generation of atherogenic lipoprotein particles as well as the production of various lipid mediators, including unsaturated fatty acids and lyso-PC. low density lipoprotein apolipoprotein B apolipoprotein E phospholipase A2 secretory PLA2 group IIA sPLA2 phosphatidylcholine group X sPLA2 group IB sPLA2 cyclooxygenase lysophosphatidylcholine fetal calf serum bovine serum albumin lipoxygenase nordihydroguaiaretic acid very low density lipoprotein high density lipoprotein high performance liquid chromatography thiobarbituric acid-reactive substances phosphate-buffered saline antibody. Initiation of atherosclerosis is characterized by the appearance of fatty streaks underlying the endothelium of large arteries. Recruitment of macrophages and their subsequent uptake of low density lipoprotein (LDL)1-derived cholesterol are the major cellular events contributing to fatty streak formation (1Ross R. Nature. 1993; 362: 801-809Crossref PubMed Scopus (10002) Google Scholar, 2Glass C.K. Witztum J.L. Cell. 2001; 104: 503-516Abstract Full Text Full Text PDF PubMed Scopus (2654) Google Scholar). Oxidative modifications in the lipid and apolipoprotein B (apoB) components of LDL are thought to drive the formation of fatty streaks (2Glass C.K. Witztum J.L. Cell. 2001; 104: 503-516Abstract Full Text Full Text PDF PubMed Scopus (2654) Google Scholar, 3Navab M. Berliner J.A. Watson A.D. Hama S.Y. Territo M.C. Lusis A.J. Shih D.M. Van Lenten B.J. Frank J.S. Demer L.L. Edwards P.A. Fogelman A.M. Arterioscler. Thromb. Vasc. Biol. 1996; 16: 831-842Crossref PubMed Scopus (613) Google Scholar), because oxidized LDL can be incorporated into the macrophages via scavenger receptors leading to the formation of foam cells that contain massive amounts of cholesterol esters. In addition, there is substantial evidence that LDL oxidation occurs in both animals and humans during the progression of atherogenesis (4Napoli C. D'Armiento F.P. Mancini F.P. Postiglione A. Witztum J.L. Palumbo G. Palinski W. J. Clin. Invest. 1997; 100: 2680-2690Crossref PubMed Scopus (814) Google Scholar). However, prospective clinical trials with antioxidants, such as vitamin E and beta carotene, in patients with pre-existing atherosclerosis, have thus far been disappointing (5Yusuf S. Dagenais G. Pogue J. Bosch J. Sleight P. N. Engl. J. Med. 2000; 342: 154-160Crossref PubMed Scopus (1777) Google Scholar). These findings suggest that other types of LDL modifications, such as that resulting from lipolytic enzymes (6Hakala J.K. Oorni K. Ala-Korpela M. Kovanen P.T. Arterioscler. Thromb. Vasc. Biol. 1999; 19: 1276-1283Crossref PubMed Scopus (46) Google Scholar), also play pivotal roles in the formation of foam cells. Phospholipase A2 (PLA2) are a diverse family of lipolytic enzymes that hydrolyze the sn-2 fatty acid ester bond of glycerophospholipids to produce free fatty acids and lysophospholipids (7Vadas P. Pruzanski W. Lab. Invest. 1986; 55: 391-404PubMed Google Scholar, 8Arita H. Nakano T. Hanasaki K. Prog. Lipid Res. 1989; 28: 273-301Crossref PubMed Scopus (162) Google Scholar). Over the past two decades, a number of PLA2s have been identified and classified into different families based on their biochemical features and primary structures (9Balsinde J. Balboa M.A. Insel P.A. Dennis E.A. Annu. Rev. Pharmacol. Toxicol. 1999; 39: 175-189Crossref PubMed Scopus (531) Google Scholar,10Six D.A. Dennis E.A. Biochim. Biophys. Acta. 2000; 1488: 1-19Crossref PubMed Scopus (1223) Google Scholar). Among them, secretory PLA2 (sPLA2) have several characteristics, including a low molecular mass (13–18 and an for of D.A. Dennis E.A. Biochim. Biophys. Acta. 2000; 1488: 1-19Crossref PubMed Scopus (1223) Google Scholar, G. M. Pharmacol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). different of have been identified in humans and D.A. Dennis E.A. Biochim. Biophys. Acta. 2000; 1488: 1-19Crossref PubMed Scopus (1223) Google Scholar, J. N. K. T. K. N. H. Hanasaki K. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, N. J. K. T. M. N. K. Hanasaki K. J. Biol. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, M. G. J. Biol. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). have that group IIA sPLA2 is in the arterial intima and is with structures and lipid droplets A. P. J. Arterioscler. Thromb. Vasc. Biol. 1997; PubMed Scopus Google Scholar, M. S. Arterioscler. Thromb. Vasc. Biol. PubMed Scopus Google Scholar, A. M. W. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, P. K. Res. 2000; PubMed Scopus Google Scholar). In addition, was to induce the of LDL leading to of LDL to J.K. Oorni K. Kovanen P.T. Arterioscler. Thromb. Vasc. Biol. 2001; PubMed Scopus Google Scholar, G. H. Oorni K. Kovanen P. Res. 2001; PubMed Scopus Google Scholar), a of in the accumulation of LDL in the on the of the arterial However, potent modifications of LDL leading to uptake by macrophages with the sPLA2 with M. Biophys. Res. PubMed Scopus Google Scholar). The in the of LDL modification be to in in the because T. H. S. H. M. J. Biol. Full Text PDF PubMed Google such as and and a very low phosphatidylcholine a major of LDL T. Kovanen P.T. Ala-Korpela M. Biochim. Biophys. Acta. 2000; 1488: PubMed Scopus Google Scholar). and other K. T. A. M. K. K. Nakano K. K. J. H. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google have the in group X sPLA2 (sPLA2-X) is one of the enzymes with a potent sPLA2-X of the classic types of group IB and and an acid that is of group K. M. G. J. Biol. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar). We have that sPLA2-X can induce potent of acid leading to cyclooxygenase as well as marked production of lysophosphatidylcholine in various cell including and cells A. T. Nakano K. H. Hanasaki K. Biochim. Biophys. Acta. 2001; PubMed Scopus Google Scholar, A. N. M. T. Nakano K. N. J. H. Hanasaki K. Biophys. 2000; PubMed Scopus Google Scholar, M. A. N. H. Hanasaki K. 2000; PubMed Scopus Google Scholar). the of found that sPLA2-X potent of unsaturated fatty acids from the fetal calf serum in These to in of serum In the the of types of and with to the of fatty acids and the of and in LDL. We the of sPLA2-X-modified LDL with oxidized LDL in of negative and apoB aggregation as well as for the in uptake into macrophages. We found that sPLA2-X potent of LDL leading to the formation of lipid droplets in the macrophages. expression of sPLA2-X in the foam cells in the arterial wall in high fat-fed in apolipoprotein E and sPLA2-X as K. T. A. M. K. K. Nakano K. K. J. H. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, A. N. M. T. Nakano K. N. J. H. Hanasaki K. Biophys. 2000; PubMed Scopus Google Scholar). was a from sPLA2-X was as K. T. A. M. K. K. Nakano K. K. J. H. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar), and and from serum albumin and nordihydroguaiaretic acid lipoxygenase from was S. M. K. T. T. M. T. M. K. T. M. J. Med. 1996; 39: PubMed Scopus Google Scholar). low density lipoprotein density LDL and high density lipoprotein from of and by as S. T. N. T. Arterioscler. Thromb. Vasc. Biol. 1997; PubMed Scopus Google Scholar). modification of LDL with LDL was with various of in of and The was by of a of LDL was with and LDL by modification was as LDL. LDL was for and with various of sPLA2 enzymes in a of The was by the of of and the fatty acids with and by liquid chromatography on a as K. T. A. M. K. K. Nakano K. K. J. H. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, H. T. M. J. Lipid Res. 1993; Full Text PDF PubMed Google Scholar). of the amounts of and in with as A. T. Nakano K. H. Hanasaki K. Biochim. Biophys. Acta. 2001; PubMed Scopus Google Scholar). The by on with a of a of acid with a of to the of and to analysis A. PubMed Scopus Google Scholar). modification with and oxidation, lipid was by the The in of thiobarbituric acid-reactive substances to the of H. T. S. A. PubMed Scopus Google Scholar). by the in of a of as H. G. H. M. Res. 1989; PubMed Scopus Google Scholar). The of LDL was by as J. Lipid Res. Full Text PDF PubMed Google Scholar). analysis of apoB LDL was and by in as H. M. J. Lipid Res. 39: Full Text Full Text PDF PubMed Google Scholar). macrophages from the of of The cells in and in cells by and macrophages with LDL LDL for The lipid of macrophages with and the cholesterol mass was by W. M. J. J. Lipid Res. 19: Full Text PDF PubMed Google Scholar). The of cholesterol was by the free cholesterol from The amounts of cellular with the cells in macrophages as and in The macrophages with LDL LDL for the cells with phosphate-buffered saline and with in for with for and with for The cells by as and in of LDL was as H. J. Biol. 1993; Full Text PDF PubMed Google Scholar). with LDL LDL for the cells with and in in in in and in with and and with a from The and from a high and high cholesterol for with via the and with in of the and the of the the and into which in the with and by an with by The into from and on with was The in for and with serum for The with in for with with for by with the was by in and of the with the in as of was by with sPLA2-X for by to the In the with and with by with We the of types of sPLA2 for the of fatty acids in a of and found that sPLA2-X the potent of unsaturated fatty acids We types of lipoprotein and from and the of for the of fatty in sPLA2-X marked of various types of unsaturated fatty acids from LDL in the acid acid acid acid whereas and caused little In there was little, if any, of fatty including and from LDL sPLA2-X The of free fatty acids by sPLA2-X and In addition, there in the of in LDL and in sPLA2-X of acid from LDL. In was during with for the of acid by types of sPLA2 during sPLA2-X whereas was little, if any, with that sPLA2-X potent of unsaturated fatty acids from LDL as with and and of acid by in LDL. of acid by LDL was with for various of acid by LDL was with various of for The acid was as The are the with in the of the of The are of is a major of in LDL T. Kovanen P.T. Ala-Korpela M. Biochim. Biophys. Acta. 2000; 1488: PubMed Scopus Google Scholar), the in LDL with in with sPLA2-X and Over of the was in LDL by sPLA2-X within and was to the of the amounts of in LDL was to sPLA2-X with the both of which have been to the of sPLA2-X K. T. A. M. K. K. Nakano K. K. J. H. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar), in of of LDL In with caused little in in LDL. of LDL with also caused production of lyso-PC. However, the of during oxidation was of that by was by both In addition, there was of unsaturated fatty acids during oxidation of LDL Treatment of LDL with caused an increase in as well as the production of whereas with types of sPLA2 findings demonstrate that sPLA2-X hydrolysis in LDL leading to the production of large amounts of and unsaturated fatty acids of in LDL with to LDL was with for and the amounts of as for the of The are of was by to in a LDL was with for and the amounts of as for the of The are of was by Modifications of in LDL to the cellular uptake of LDL and the formation of foam cell macrophages (2Glass C.K. Witztum J.L. Cell. 2001; 104: 503-516Abstract Full Text Full Text PDF PubMed Scopus (2654) Google Scholar). We the of sPLA2-X on the charge of LDL by in oxidized LDL was characterized by with LDL. Treatment with sPLA2-X also caused of LDL. was of and marked was of with In the of LDL with was during of in of that the increase of negative charge in LDL is on the of the of sPLA2-X on the modification of apoB by in excessive aggregation and fragmentation of apoB was in oxidized LDL of In apoB in the LDL was with aggregation of with LDL. in apoB of LDL with and These findings demonstrate that sPLA2-X an increase in the negative charge of LDL with little modification of the of LDL for uptake into macrophages. of macrophages to LDL for the cellular of free and cholesterol in the cholesterol mass was in the macrophages with and was that by LDL that by oxidized LDL. The cellular lipid droplets with and by in there was little in the macrophages with LDL. In the formation of lipid droplets was in macrophages with sPLA2-X-modified LDL and lipid droplets in macrophages with oxidized LDL Lipid droplets be with LDL and was during the modification of LDL with sPLA2-X by with the formation of lipid droplets was In lipid formation was was to the of sPLA2-X during with macrophages of macrophages with sPLA2-X lipid formation with and the and lipid formation in the macrophages with sPLA2-X-modified LDL These findings suggest that formation of lipid droplets is on the modification of LDL and is to the of scavenger of macrophages the of of macrophages with LDL. LDL and oxidized LDL by LDL with for macrophages with LDL LDL oxidized LDL for macrophages and with The of macrophages with LDL. LDL was with for macrophages with LDL for In LDL was with sPLA2-X in the of for with LDL for in the of The of in both was the cells and with and The the in the cellular lipid droplets by In contrast to the macrophages with LDL non-membrane-bound lipid droplets with in the cytoplasm of macrophages with LDL B accumulation of cholesterol was in the of the cells with LDL for In there non-membrane-bound lipid droplets in the macrophages with oxidized LDL extensive accumulation of multilayered structures was found in their cytoplasm structures have been in the cells of lesions in the oxidized LDL-treated and have been as lipid N. Full Text PDF PubMed Scopus Google structures large amounts of cholesterol A.M. J. PubMed Scopus Google Scholar). However, structures found in cells with thus that sPLA2-X-modified LDL to LDL. the of sPLA2-X in a of atherogenesis N. J. Clin. Invest. PubMed Scopus Google Scholar). lesions with an atherogenic the of lesions N. J. Clin. Invest. PubMed Scopus Google Scholar). the expression of sPLA2 enzymes in with a high and high cholesterol for In the vessels from there lesions and if any, for sPLA2-X expression In the from in the multilayered foam cell lesions in the arterial intima as well as in cells in the of the artery wall These for because of the with a of sPLA2-X the and in with the cell the macrophages with The sPLA2-X in the arterial intima found to well with the of the macrophages to the in macrophages A. N. M. T. Nakano K. N. J. H. Hanasaki K. Biophys. 2000; PubMed Scopus Google Scholar). with for analysis been in the have a from the two with M. A.M. Cell. Full Text PDF PubMed Scopus (531) Google Scholar), there was with The of foam cells is a of both and and cholesterol accumulation in macrophages is by uptake of of LDL (2Glass C.K. Witztum J.L. Cell. 2001; 104: 503-516Abstract Full Text Full Text PDF PubMed Scopus (2654) Google Scholar). The that sPLA2-X lipolytic modification of LDL leading to the accumulation of cholesterol ester in macrophages. In addition, the expression of sPLA2-X was in atherogenic lesions in mice. These findings suggest in to modifications, modification by sPLA2-X is one of the mechanisms for the generation of atherogenic LDL. sPLA2-X-modified LDL features in with oxidized LDL in of the of with production as well as the increase in negative However, marked in several both The increase in production during sPLA2-X was with of large amounts of unsaturated fatty which was in contrast with the of during LDL oxidation lipid and oxidized fatty acids are efficiently by PLA2 D.M. J. 1999; PubMed Scopus Google Scholar), the fatty acids be during this process. of production in LDL with sPLA2-X with oxidized LDL the which also be to in the PLA2 is to play an in atherosclerosis and by various cellular such as the of various and cell N. M.A. J. Clin. Invest. PubMed Scopus Google Scholar, S. S. A. PubMed Scopus Google Scholar), sPLA2-X-modified LDL cellular events to oxidized LDL M. Berliner J.A. Watson A.D. Hama S.Y. Territo M.C. Lusis A.J. Shih D.M. Van Lenten B.J. Frank J.S. Demer L.L. Edwards P.A. Fogelman A.M. Arterioscler. Thromb. Vasc. Biol. 1996; 16: 831-842Crossref PubMed Scopus (613) Google Scholar, S. Witztum J.L. N. Engl. J. Med. 1989; PubMed Google Scholar). LDL modifications with sPLA2-X and oxidation is the modification of apoB with caused aggregation and fragmentation of apoB in contrast to if any, sPLA2-X been that LDL oxidation the production of fatty acid that can oxidation of apoB with an increase in the negative charge of LDL as well as the generation of structures by the scavenger receptors M. M. J. Biol. 1989; Full Text PDF PubMed Google Scholar). The of modification of apoB during sPLA2-X the of different mechanisms for the increase in the negative charge of LDL. We found that the of unsaturated fatty acids during sPLA2-X are to LDL. the of in the of fatty acids from sPLA2-X-modified LDL leading to a in negative However, the accumulation of ester as well as the formation of lipid droplets in macrophages and also in LDL with sPLA2-X in the of and K. These findings suggest that the negative charge of LDL to the fatty acids for the uptake into the macrophages. the mechanisms potent of LDL the of apoB leading to the uptake into as for LDL with PLA2 M. W. G. J. Lipid Res. Full Text PDF PubMed Google Scholar). the unsaturated fatty acids be incorporated into the macrophages leading to the production of lipid acid be by leading to the production of acid that can as an for involved in foam cell formation J.S. M. C. Witztum J.L. C.K. Nature. 1999; PubMed Scopus Google Scholar). fatty acids and oxidized LDL to induce the expression of fatty one of the involved in foam cell formation K. M.A. J. S. Med. 2001; PubMed Scopus Google Scholar), sPLA2-X also expression in macrophages via modification of LDL. are to the cellular mechanisms underlying the potent uptake of sPLA2-X-modified LDL. In the lesions in types of lipid have been in foam non-membrane-bound lipid lipid and cholesterol N. Full Text PDF PubMed Scopus Google Scholar, J. Google Scholar, K. PubMed Scopus Google Scholar, H. S. Lab. Invest. Google Scholar, J. 1986; Google Scholar). In the non-membrane-bound lipid droplets and cholesterol in the cytoplasm of macrophages with LDL whereas structures found in the cytoplasm of the cells with oxidized LDL. was with that and oxidized LDL are in different into macrophages C. R. R. J. Lipid Res. 39: Full Text Full Text PDF PubMed Google Scholar, M. Arterioscler. Thromb. Vasc. Biol. 1999; 19: PubMed Scopus Google Scholar, H. K. R. M. M. T. Biochim. Biophys. Acta. 2000; PubMed Scopus Google Scholar). The in may be to the of oxidized LDL in in that to lipid accumulation M. J. Biol. Full Text PDF PubMed Google the in uptake and oxidized LDL M. Arterioscler. Thromb. Vasc. Biol. 1999; 19: PubMed Scopus Google Scholar). The formation of non-membrane-bound lipid droplets by LDL a to that of LDL. The large lipid droplets have been in the fatty streak in Arterioscler. Thromb. PubMed Scopus Google Scholar). In addition, the non-membrane-bound lipid droplets have been to be the of lipid accumulation the of the whereas the lipid accumulation found in oxidized LDL was in the of lesions in J. Google Scholar, K. PubMed Scopus Google Scholar). In this sPLA2-X be one of the involved in the of because LDL is an In the on the and oxidized LDL in various However, modifications can in because been to modification of LDL by the with that is in the atherogenic lesions S. J. Lipid Res. Full Text PDF PubMed Google Scholar, J. R. PubMed Scopus Google Scholar, S. S. C.K. Witztum J.L. S. A. PubMed Scopus Google Scholar). of the caused marked in lipid and atherogenesis in T. Witztum J.L. R. S. J. Clin. Invest. 1999; PubMed Scopus Google Scholar, T. Witztum J.L. J. 2001; PubMed Scopus Google Scholar), the of oxidation and sPLA2 enzymes in LDL modification In the expression of sPLA2-X was in foam cells in the arterial intima as well as in cells sPLA2-X is a K. T. A. M. K. K. Nakano K. K. J. H. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, K. M. G. J. Biol. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar), be from foam cells and cells to in the in the in atherogenic the expression of sPLA2-X in the by a high and high cholesterol also expression in foam cell lesions of the arterial intima in S. and K. in of the expression of sPLA2-X in lesions as well as in patients with atherosclerosis are to roles in Among the potent of LDL was on with which may have been to the major in LDL T. Kovanen P.T. Ala-Korpela M. Biochim. Biophys. Acta. 2000; 1488: PubMed Scopus Google Scholar, K. T. A. M. K. K. Nakano K. K. J. H. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). fatty acid was during of LDL with of which was with the of on LDL M. P. S. W. Google Scholar). However, is in the and expression was in the lesions of humans A. P. J. Arterioscler. Thromb. Vasc. Biol. 1997; PubMed Scopus Google that in atherogenesis is to modification of LDL was during However, J.K. Oorni K. Kovanen P.T. Arterioscler. Thromb. Vasc. Biol. 2001; PubMed Scopus Google have that of LDL with for a in of LDL leading to and of LDL to also been that the expression of is in arterial the of is the with and other structures M. S. Arterioscler. Thromb. Vasc. Biol. PubMed Scopus Google Scholar, P. K. Res. 2000; PubMed Scopus Google Scholar). These findings suggest that is involved in the accumulation of in the of the arterial whereas sPLA2-X of LDL to foam cell formation within the arterial W. PubMed Scopus Google have that of sPLA2 with a potent D.A. Dennis E.A. Biochim. Biophys. Acta. 2000; 1488: 1-19Crossref PubMed Scopus (1223) Google Scholar), can also hydrolyze lipoprotein with also revealed the potent lipolytic modification of LDL and are to the of in lipoprotein modifications to the lipid formation in macrophages. However, was to acid acid from W. PubMed Scopus Google Scholar), which was with fatty acid Dennis E.A. Biochim. Biophys. Acta. PubMed Scopus Google Scholar). In sPLA2-X can induce potent of acid from LDL with on the of of acid to the is to be by macrophages M.A. J. J.A. Dennis E.A. J. Biol. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar), there are on expression in the including is to the in for because of for have been to with Dennis E.A. Biochim. Biophys. Acta. PubMed Scopus Google Scholar). analysis in of the for lipoprotein modifications and the expression in lesions is to the of and other types of such as and in the progression of atherosclerosis. of LDL have been to be with of A. S. Dagenais 1997; PubMed Scopus Google Scholar). LDL and cholesterol in the LDL in D.M. J. Lipid Res. 1996; Full Text PDF PubMed Google and is with to oxidation J. Lipid Res. Full Text PDF PubMed Google and uptake into macrophages G. G. J. Lipid Res. Full Text PDF PubMed Google Scholar). P. G. J. Biol. 1999; Full Text Full Text PDF PubMed Scopus Google have that sPLA2 from can modifications of the of the sPLA2 enzymes involved In the sPLA2-X lipolytic on LDL to induce modification of LDL leading to uptake into macrophages. of LDL during sPLA2-X have been the of this sPLA2 to the formation of LDL of unsaturated fatty acids was also in and with revealed that sPLA2-X can induce modification of to LDL in of the of and in and negative findings suggest that sPLA2-X is a that the of into the atherogenic have that have of with M.C. Lusis A.J. J. Lipid Res. 1997; Full Text PDF PubMed Google Scholar), because of this the of and of uptake of C. W. J. Biol. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). The of sPLA2-X to lipoprotein modifications also be in including the generation of mice. sPLA2-X potent lipolytic in as well as lipid production in cell such as S. M. M. G. J. Biol. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, M. A. S. M. K. A. G. J. Biol. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar), be with to the of of serum In have here that sPLA2-X modification of LDL leading to formation oxidation of LDL. In addition, a of lipid are during of LDL by which also to the progression of atherosclerosis. the atherogenic features of oxidized prospective clinical trials with have been to have been (5Yusuf S. Dagenais G. Pogue J. Bosch J. Sleight P. N. Engl. J. Med. 2000; 342: 154-160Crossref PubMed Scopus (1777) Google Scholar). the of the of sPLA2 as be in We for the of We are to and for We also for

References

67